Effect of Entacapone on Bodyweight Loss in Obese Population
Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled, double blind clinical trial. The purpose of this study is
to investigate the weight loss efficacy of entacapone. In this study, participants are
randomly divided into entacapone and placebo groups. The percentage change in body weight,
the body mass index, waist circumstance, extent of fatty liver, quantity of visceral fat,
serum insulin, serum triglyceride and the adverse effects are compared between the two
groups.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kaichun Wu
Collaborator:
National Institute of Biological Sciences, Beijing